GlaxoSmithKline helps immunometabolism startup Sitryx to $30M round

GlaxoSmithKline helps immunometabolism startup Sitryx to $30M round

Source: 
Fierce Biotech
snippet: 

GlaxoSmithKline has helped Sitryx to a $30 million (€26 million) funding round. Newly formed British biotech Sitryx will use the money and its relationship with GSK to move immunometabolism assets toward human testing.